Literature DB >> 21125407

Problems with 'focal segmental glomerulosclerosis'.

Alexander J Howie1.   

Abstract

The term 'focal segmental glomerulosclerosis (FSGS)' has been applied to many different conditions. All classifications of 'FSGS', including those describing 'variants', perpetuate the misconceptions that the entities included have something in common and that the term 'FSGS' has some value. With a rigorous approach to renal biopsies showing segmental lesions, especially with knowledge of clinical circumstances and with detailed analysis of features such as the appearance of lesions and their position within glomeruli, a pathologist can provide information that is clinically more useful than merely the bald diagnosis 'FSGS'. More precise terms should be used. 'Overload changes' can be used to describe the changes seen in reduced renal mass. 'Tip changes' can be seen in many conditions and are not a disease in themselves. 'The glomerular tip lesion as originally defined' means the occurrence of tip changes in otherwise normal glomeruli, in the nephrotic syndrome. 'Early classical segmental sclerosing glomerulopathy' is the combination of tip changes and otherwise abnormal glomeruli, in the nephrotic syndrome. 'Late classical segmental sclerosing glomerulopathy' means segmental lesions at various sites within glomeruli, in the nephrotic syndrome. 'Collapsing glomerulopathy' is distinctive, and its inclusion in classifications emphasises the lack of specificity of 'FSGS'.

Entities:  

Mesh:

Year:  2010        PMID: 21125407     DOI: 10.1007/s00467-010-1701-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  54 in total

1.  A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis.

Authors:  A R RICH
Journal:  Bull Johns Hopkins Hosp       Date:  1957-04

2.  Serial morphometric analysis of sclerotic lesions in primary "focal" segmental glomerulosclerosis.

Authors:  G Fuiano; N Comi; P Magri; V Sepe; M M Balletta; C Esposito; F Uccello; A Dal Canton; G Conte
Journal:  J Am Soc Nephrol       Date:  1996-01       Impact factor: 10.121

3.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

4.  Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis.

Authors:  Bart Smeets; Maria Lucia Angelotti; Paola Rizzo; Henry Dijkman; Elena Lazzeri; Fieke Mooren; Lara Ballerini; Eliana Parente; Costanza Sagrinati; Benedetta Mazzinghi; Elisa Ronconi; Francesca Becherucci; Ariela Benigni; Eric Steenbergen; Laura Lasagni; Giuseppe Remuzzi; Jack Wetzels; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

5.  Glomerular tip changes in childhood minimal change nephropathy.

Authors:  Alexander J Howie; Anju Agarwal; Neil J Sebire; Richard S Trompeter
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

6.  Different types of segmental sclerosing glomerular lesions in six experimental models of proteinuria.

Authors:  A J Howie; T Kizaki; M Beaman; C M Morland; R J Birtwistle; D Adu; J Michael; A J Williams; J Walls; M Matsuyama
Journal:  J Pathol       Date:  1989-02       Impact factor: 7.996

7.  Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population--epidemiology and outcome.

Authors:  Jeroen K J Deegens; Eric J Steenbergen; George F Borm; Jack F M Wetzels
Journal:  Nephrol Dial Transplant       Date:  2007-08-17       Impact factor: 5.992

8.  Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis.

Authors:  Wilhelm Kriz; Bruni Hähnel; Hiltraud Hosser; Tammo Ostendorf; Soeren Gaertner; Bettina Kränzlin; Norbert Gretz; Fujio Shimizu; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

9.  Pathogenesis of segmental glomerular changes at the tubular origin, as in the glomerular tip lesion.

Authors:  A J Howie; S J Lee; J Sparke
Journal:  J Pathol       Date:  1995-10       Impact factor: 7.996

10.  Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy.

Authors:  Laura Barisoni; H William Schnaper; Jeffrey B Kopp
Journal:  Arch Pathol Lab Med       Date:  2009-02       Impact factor: 5.534

View more
  5 in total

Review 1.  Target organ damage in African American hypertension: role of APOL1.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 2.  Genetic testing in renal disease.

Authors:  Detlef Bockenhauer; Alan J Medlar; Emma Ashton; Robert Kleta; Nick Lench
Journal:  Pediatr Nephrol       Date:  2011-05-27       Impact factor: 3.714

Review 3.  Variations of type IV collagen-encoding genes in patients with histological diagnosis of focal segmental glomerulosclerosis.

Authors:  Erol Demir; Yasar Caliskan
Journal:  Pediatr Nephrol       Date:  2019-06-28       Impact factor: 3.714

Review 4.  Speciated High-Density Lipoprotein Biogenesis and Functionality.

Authors:  C Rosales; W S Davidson; B K Gillard; A M Gotto; H J Pownall
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

Review 5.  Genetic studies of focal segmental glomerulosclerosis: a waste of scientific time?

Authors:  Alexander J Howie
Journal:  Pediatr Nephrol       Date:  2018-12-27       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.